Request Strategic Dialogue → Arrange Dayi-Anren Site Visit
THE ARTEMIS BIOTECH BRIDGE™

Unlocking the Chengdu-Dayi-Anren (CDA) biotech corridor for global markets

Peptide therapeutics, GLP-1 agonists, and biologics manufacturing. A leading position in global peptide API supply, anchored in the Chengdu-Dayi-Anren (CDA) corridor.

Beijing policy coordination · Chengdu-Anren manufacturing delivery · two decades of regulatory fluency

Request Peptide Technical Datasheet → Arrange Dayi-Anren Site Visit
GlobalPartner Ecosystem
SignificantGlobal APIs
Two DecadesYears in China
GlobalExport Markets
↓

Investment Thesis

Rothschild Biotech is a Western-facing platform connecting global biotech markets with the Chengdu-Dayi-Anren (CDA) corridor.

Sichuan is positioned as a national biotech hub for peptide therapeutics, biologics, and gene therapy manufacturing. We are positioned at the center of this strategic priority, with two decades of regulatory fluency and established presence in the CDA corridor's supply chain.

Our flagship capabilities - peptide therapeutics and GLP-1 agonists - represent a leading peptide manufacturing ecosystem in the CDA corridor. The corridor is among the world's major peptide API supply regions. Manufacturing operates under cGMP (21 CFR Part 210/211) frameworks, with certification status verifiable under NDA.

"China's biotech economy is projected to reach $50B+ by 2030. We are positioned to capture a significant share through our established presence in the CDA corridor."

- Dr. Michael Rothschild MD · Market-size figures are positioning estimates drawn from published industry analyses (2025) and are not guarantees.

Peptide Therapeutics

Peptide API manufacturing. GLP-1 agonists, biologics, and gene therapy capabilities. cGMP-aligned (21 CFR Part 210/211).

Specification Peptide API Manufacturing
Annual CapacitySignificant
Key ProductsSemaglutide - Tirzepatide - Retatrutide - GLP-1 Agonists
Manufacturing Facilitiesmultiple cGMP facilities
Global Market PositionSignificant share of global peptide APIs
Supply Chain100% localized supply chain
Export Countriesinternational markets served
Regulatory StatusNMPA-registered - cGMP Compliant (21 CFR Part 210/211)

Global Agent and Distribution: Rothschild Biotech coordinates international agency and distribution relationships for peptide API manufacturing from the CDA corridor to markets outside China.

Peptide Therapeutics

GLP-1 agonists, metabolic peptides, and oncology peptides. Significant annual capacity. Significant global market share.

cGMP Manufacturing

cGMP facilities. Full compliance with NMPA and international quality standards. Localized supply chain.

Global Reach

Export to international markets. 100% local supply chain. Complete vertical integration from R&D to commercial deployment.

The Biotech Partner Network

The Artemis Biotech Bridge™ is building a tiered ecosystem across the CDA corridor. Current engagements span early discussions through confirmed partnerships.

✓ Confirmed Partner: Profile available under NDA.

○ 32 additional partners in discussion. Profiles available under NDA.

Tier 1
National Flagships
Multiple partners · Confirmed & in discussion
State-level primes and national flagship manufacturers with direct access to China's biotech programs. Profiles available under NDA.
Request Details →
Tier 2
Local Manufacturers
Multiple partners · In discussion
Private manufacturers with international certifications (FDA, EU GMP) providing peptide synthesis, biologics, and API capacity. Profiles available under NDA.
Request Details →
Tier 3
R&D & Testing
Multiple partners · In discussion
Government-affiliated certification centers, testing institutions, and R&D partners supporting the CDA corridor ecosystem. Profiles available under NDA.
Request Details →
Request Partner Details →

The Chengdu Biotech Belt

China - Sichuan Province CHENGDU Biotech Capital Rothschild HQ 333 Anren - Dayi Beijing - Policy Hub Shanghai Hong Kong Legend Biotech Belt Rothschild HQ Major Hubs

Established presence in the CDA corridor - a national biotech hub

The CCPFL Doctrine
"The crest is not a symbol of privilege. It is a symbol of duty." - Dr. Michael Rothschild MD
C Class Dignity - Refinement - Education
C Culture Heritage - Tradition - Global
P Polite Society Dialogue - Respect - Civility
F Family Generations - Stewardship
L Legacy Archive - Future - Eternal
The permanent governance framework for multi-generational industrial stewardship - Since 2006

The Rothschild Family

Multi-generational stewardship. Austrian-Vienna branch. CCPFL governance.

The Rothschild Legacy

Dr. Michael Rothschild MD, representing the Austrian-Vienna branch of the Rothschild family, is building a multi-generational legacy in China rooted in the CCPFL Doctrine - Class, Culture, Polite Society, Family, and Legacy.

His children, China Jade Rothschild (born in China) and Melina Ivy Rothschild (born in Chengdu, China), represent the next generation. Both are MADE IN CHINA — born in China and being raised in Chengdu, immersed in Chinese culture and the CCPFL values that guide the Artemis Biotech Bridge™ ecosystem.

"We are not building for ourselves. We are building for our children, and their children, and all the generations to come." - Dr. Michael Rothschild MD

Disclaimer: Rothschild Biotech represents the Austrian-Vienna branch of the Rothschild family, operating independently in China. This entity operates independently and has no affiliation with any other Rothschild family enterprises.

Rothschild Intelligence Library

Featured Research Reports

Institutional-grade research covering the CDA corridor, peptide therapeutics, biologics manufacturing, and the Artemis Biotech Bridge™ initiative. The complete library catalog is available to qualified institutional partners.

Request Complete Library Catalog →

Investor Data Room

Comprehensive due diligence materials, financials, and operational data are available to qualified institutional partners under NDA.

Request Data Room Access →

Request Peptide Information

How can we build a legacy together?

There is no web submission form on this site.
To make inquiries, reach out via LinkedIn, direct email, or WeChat using the Chinese mobile number below.
Please include a brief background about your organization and your interest in peptide therapeutics / Artemis Biotech Bridge™ within your initial message.

LinkedIn

Dr. Michael Rothschild MD

Preferred for institutional inquiries

Email

biotech@rothschildcorp.com

For documented correspondence

WeChat

+86-189-2244-4800

For China-based partners

Address

333 Yingbin Road Section 1, Anren Town
Dayi County, Chengdu
Sichuan 611330, PRC

Note: WeChat is for China-based institutional partners only. International inquiries should use LinkedIn or email.

Connect With Us

We respond to all inquiries within 48 hours.

Our Digital Ecosystem

Rothschild Biotech is the flagship life sciences platform within a broader ecosystem of six interconnected divisions spanning biotech, clean energy, aerospace, policy, and commerce. Each division operates independently while leveraging shared resources, regulatory expertise, and the CCPFL governance framework.

Corp HQ — Group Headquarters & Manufacturing
rothschildcorp.cn
The operational nerve center of the Rothschild ecosystem in China. Based in Chengdu-Anren, Corp HQ oversees manufacturing, supply chain integration, and group-wide strategic coordination across all divisions.
Key Functions: Manufacturing · Supply Chain · Group Strategy · Governance
Visit Corp HQ →
Beijing — Policy & Institutional Liaison
rothschild.bj.cn
The policy bridge between the Rothschild ecosystem and Chinese regulatory authorities. Beijing serves as the primary liaison for NMPA, FDA, and other government relations.
Key Functions: Regulatory Affairs · Government Relations · Policy Strategy
Visit Beijing →
Shanghai — Commercial & Finance Hub
rothschild.sh.cn
The commercial and financial engine of the ecosystem. Shanghai hosts investor relations, capital markets activities, and commercial partnerships with global institutions.
Key Functions: Investor Relations · Capital Markets · Commercial Partnerships
Visit Shanghai →
Space — Aerospace Division
rothschildspace.com
The aerospace innovation arm of the Rothschild ecosystem. Space focuses on autonomous flight systems, UAV manufacturing, and the intersection of aerospace with biotech and clean energy applications.
Key Functions: Autonomous Flight · UAV Manufacturing · Low-Altitude Logistics
Visit Space →
Hydrogen — Clean Energy Division
rothschildhydrogen.com
The clean energy division of the Rothschild ecosystem. Hydrogen develops and deploys green hydrogen solutions for industrial and energy applications, including H-Brick storage, fuel cells, and sustainable energy systems.
Key Functions: H-Brick Storage · Green Hydrogen · Fuel Cells · Sustainability
Visit Hydrogen →
Biotech — Life Sciences Division
rothschildbiotech.com
The flagship life sciences platform of the Rothschild ecosystem. Biotech specializes in peptide therapeutics, GLP-1 agonists, and biologics manufacturing in the Chengdu-Dayi-Anren corridor.
Key Functions: Peptide APIs · GLP-1 Agonists · Biologics Manufacturing · CDMO
Current Site

Ecosystem at a Glance

Divisions: 6 Partners: Global Reports: Extensive Nations: 16 Governance: CCPFL Doctrine Founded: 2006 Years in China: Two Decades
Genuine visitors: —